In Vivo Depletion of Lymphotoxin-Alpha Expressing Lymphocytes Inhibits Xenogeneic Graft-versus-Host-Disease

The use of monoclonal antibodies for the treatment of graft-versus-host disease following allogeneic stem cell transplantation

(2011) Alessandro Busca   EXPERT OPINION ON BIOLOGICAL THERAPY

Selective Targeting of Human Alloresponsive CD8+ Effector Memory T Cells Based on CD2 Expression

(2010) D. J. Lo et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The role of B cell depleting therapy in graft versus host disease after allogeneic hematopoietic cell transplant

(2010) Amin M. Alousi et al.   LEUKEMIA & LYMPHOMA

Resurrection of a clinical antibody: Template proteogenomic de novo proteomic sequencing and reverse engineering of an anti-lymphotoxin-α antibody

(2010) Natalie E. Castellana et al.   PROTEOMICS

Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease

(2009) S. Sarantopoulos et al.   BLOOD

New perspectives on the biology of acute GVHD

(2009) S Paczesny et al.   BONE MARROW TRANSPLANTATION

Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease

(2009) John Wilson et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Targeted depletion of lymphotoxin-α–expressing TH1 and TH17 cells inhibits autoimmune disease

(2009) Eugene Y Chiang et al.   NATURE MEDICINE

Chronic GVHD as an autoimmune disease

(2008) Alan Tyndall et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Current and novel therapies in acute GVHD

(2008) Vincent T. Ho et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Prevention and treatment of acute GvHD

(2008) C Messina et al.   BONE MARROW TRANSPLANTATION

Human fetal lymphoid tissue–inducer cells are interleukin 17–producing precursors to RORC+ CD127+ natural killer–like cells

(2008) Tom Cupedo et al.   NATURE IMMUNOLOGY